In Stents, How the Mighty are Falling--Fast
Executive SummaryIt's no surprise that Johnson & Johnson no longer owns the stent market. What's surprising is how fast it lost it.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.